Drugs / CETUXIMAX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02015923 Background | Dec 2013 → Jun 2019 | metastasis from malignant tumor of colon | Hospital Universitari de Bellvitge | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CETUXIMAX | “CETUXIMAX / BEVACIZUMAB/PANITUMUMAB” NCT02015923 ↗ |